| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0966-3274(02)00007-2 |
| P698 | PubMed publication ID | 12180827 |
| P2093 | author name string | Tiercy JM | |
| P2860 | cites work | The molecular determination of HLA-Cw alleles in the Mandenka (West Africa) reveals a close genetic relationship between Africans and Europeans | Q28138939 |
| Analysis of the distribution of HLA-B alleles in populations from five continents | Q28199297 | ||
| The molecular basis of allorecognition | Q28268279 | ||
| Population biology of antigen presentation by MHC class I molecules | Q28276052 | ||
| Search for an unrelated HLA-compatible stem cell donor | Q33765205 | ||
| The HLA system. First of two parts | Q34023681 | ||
| Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. | Q34218150 | ||
| HLA DNA typing and transplantation | Q34241099 | ||
| Definition of HLA-DQ as a transplantation antigen | Q37094022 | ||
| Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization | Q37577418 | ||
| Current methodologies of human leukocyte antigen typing utilized for bone marrow donor selection. | Q40835575 | ||
| The biochemistry and cell biology of antigen processing and presentation | Q40898211 | ||
| HLA-DRB1 matched kidneys are preferentially HLA-A and -B compatible and survive longer | Q41011593 | ||
| Molecular characterization of HLA-C incompatibilities in HLA-ABDR-matched unrelated bone marrow donor-recipient pairs. Sequence of two new Cw alleles (Cw*02023 and Cw*0707) and recognition by cytotoxic T lymphocytes | Q41106347 | ||
| Genetic diversity of HLA-A2: evolutionary and functional significance | Q41166709 | ||
| Hematopoietic stem cell transplants from unrelated donors | Q41561719 | ||
| Factors influencing the outcome of bone marrow transplants using unrelated donors. | Q41561723 | ||
| Equitable allocation of HLA-compatible kidneys for local pools and for minorities | Q42599936 | ||
| Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program | Q44216272 | ||
| Molecular diversity of HLA-A*02 in Asian Indians: predominance of A*0211. | Q47889897 | ||
| The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens | Q48738418 | ||
| Validation of DNA-based HLA-A and HLA-B testing of volunteers for a bone marrow registry through parallel testing with serology | Q48740529 | ||
| HLAMMATCHMAKER: a molecularly based donor selection algorithm for highly alloimmunized patients. | Q52066610 | ||
| Oligotyping of HLA-A2, -A3, and -B44 subtypes. Detection of subtype incompatibilities between patients and their serologically matched unrelated bone marrow donors. | Q53380412 | ||
| Nomenclature for factors of the HLA system, 2000 | Q57337191 | ||
| Marrow transplantation from unrelated volunteer donors | Q71839473 | ||
| DNA HLA-DR typing results of 4000 kidney transplants | Q72216467 | ||
| Presentation and recognition of major and minor histocompatibility antigens | Q72787216 | ||
| Evaluation of HLA matching for CREG antigens in Europe | Q73156784 | ||
| Clinical implications of DNA typing in organ transplantation. The Collaborative Transplant Study | Q73279221 | ||
| Cytotoxic T-lymphocyte precursor frequency (CTLp-f) as a tool for distinguishing permissible from non-permissible class I mismatches in T-cell-depleted allogeneic bone marrow transplantation | Q73309649 | ||
| Recognition of major histoincompatibilities after transplantation with marrow from HLA closely matched donors | Q73483228 | ||
| European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation | Q73533025 | ||
| The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor-recipient pairs | Q73562870 | ||
| High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs | Q73599631 | ||
| The biological significance of HLA-DP gene variation in haematopoietic cell transplantation | Q73740986 | ||
| HLA class I DNA typing of 215 "HLA-A, -B, -DR zero mismatched" kidney transplants | Q73829235 | ||
| Outcome of unrelated bone marrow donor searches in 174 children resulting in 45 patients transplanted in the HLA-matched and -mismatched situation | Q74082576 | ||
| Bone marrow transplantation with unrelated donors: what is the probability of identifying an HLA-A/B/Cw/DRB1/B3/B5/DQB1-matched donor? | Q74302224 | ||
| Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations | Q74480792 | ||
| HLA-C mismatches induce strong cytotoxic T-cell reactivity in the presence of an additional DRB/DQB mismatch and affect NK cell-mediated alloreactivity | Q74554245 | ||
| Comparison of serological and DNA PCR-SSP typing results for HLA-A and HLA-B in 421 Black individuals: a Collaborative Transplant Study report | Q77124605 | ||
| Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience | Q77136345 | ||
| Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation | Q78008339 | ||
| P433 | issue | 2-4 | |
| P304 | page(s) | 173-180 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Transplant Immunology | Q15758510 |
| P1476 | title | Molecular basis of HLA polymorphism: implications in clinical transplantation | |
| P478 | volume | 9 |
| Q39148353 | (AT) repeat in the 3' untranslated region of the CTLA-4 gene and susceptibility to acute allograft rejection in Tunisian renal transplantation |
| Q30847240 | A fault-tolerant method for HLA typing with PacBio data |
| Q40710729 | A novel HLA-DQ allele, HLA-DQB1*05:48, found in the Saudi Stem Cells Donor Registry. |
| Q43771114 | An informative set of SSLP markers and genomic profiles in the rat MHC, the RT1 complex |
| Q53108441 | Anti-HLA sensitization after kidney allograft nephrectomy: changes one year post-surgery and beneficial effect of intravenous immunoglobulin. |
| Q46621729 | Anti-human leukocyte antigen antibodies are present in blood of blood donors: is therapy with blood preparations safe for graft recipients? |
| Q50635804 | Association of UGT2B7, UGT1A9, ABCG2, and IL23R polymorphisms with rejection risk in kidney transplant patients. |
| Q40057738 | Description of a novel HLA-DQB1 allele, HLA-DQB1*06:126, in the Saudi stem cell donor registry. |
| Q36028231 | Genetic aspects of immune-mediated adverse drug effects |
| Q36852480 | Genetic polymorphisms at HLA-A, -B, and -DRB1 loci in Han population of Xi'an city in China |
| Q47148549 | HLA genotyping by next-generation sequencing of complementary DNA. |
| Q38000379 | HLA techniques: typing and antibody detection in the laboratory of immunogenetics |
| Q42214078 | HLA-DRB1 and susceptibility to kidney allograft rejection in Southern Iranian patients. |
| Q45350735 | Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT. |
| Q37953441 | Human leucocyte antigen typing: techniques and technology, a critical appraisal |
| Q40695221 | Identification of seven novel HLA class I alleles in New Zealand |
| Q48108536 | Identification of the HLA-DQB1*06:123 allele in an unrelated stem cell donor from the Saudi Registry. |
| Q79841403 | Impact of HLA class I and class II DNA high-resolution HLA typing on clinical outcome in adult unrelated stem cell transplantation after in vivo T-cell depletion with alemtuzumab |
| Q37639145 | Influence of Donors' and Recipients' HLA Typing on Renal Function Immediately After Kidney Transplantation. |
| Q37602004 | Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells. |
| Q45388505 | Stem cell source-dependent reconstitution of FOXP3+ T cells after pediatric SCT and the association with allo-reactive disease |
| Q36453413 | The influence of inherited and noninherited parental antigens on outcome after transplantation |
| Q40664024 | Three new HLA-C alleles (HLA-C*14:02:13, HLA-C*15:72 and HLA-C*15:74) in Saudi bone marrow donors |
| Q47998827 | Two novel alleles HLA-DRB1*11:150 and HLA-DRB1*14:145 identified in Saudi individuals. |
| Q53782071 | [The HLA system in the Moroccan population: General review]. |
Search more.